Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

New Molecular Entity
Yes

Highest Development Phases

Marketed
Acne vulgaris

Most Recent Events

27 Jul 2017
Valeant Pharmaceuticals International acquired Ortho Dermatologics in 2011 and changed the name of the later to Valeant Dermatology. Subsequently, in July 2017, it was rebranded to Ortho Dermatologics